Today, Medicenna Therapeutics Corp shares closed at $2.44 after opening the day at $2.39. It traded at a low of $2.39 to a high of $2.49.

Share prices boosted 2.09% from the previous day's close of $2.39.

During the day across North America, the TSX Composite closed 1.42% at 22259.47, the S&P 500 closed 1.26% at 5127.79, the Dow Jones Industrial Average closed 1.18% at 38675.68 and the Nasdaq Composite closed 1.99% at 16156.33.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 95,461 shares was traded during the last trading day, with total trades of 145, with an average volume of 83,649 over 5 days.

The TSX market on the whole today saw 3,516 price advancers against 1,683 declines and 111 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.68 (April 29,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 141.58% in the last 12 months, while in 2024, they have risen 480.95%.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $178.72 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Medicenna Therapeutics Corp's consensus rating is "Strong Buy" based on 2 analysts according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..